References
- Stanghellini V. Three month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic International Gastroenterology Surveillance study (DIGEST). Scand J Gastroenterol 1999; 34(suppl 231)20–28
- Kiljander T O, Laitinen J O. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004; 126: 1398–41403
- Legget J L, Johnston B T, Mills M, Gamble J, Heaney L. Prevalence of gastroesophageal reflux in difficult asthma. Chest 2005; 127: 1227–1231
- Ten Brinke A, Sterk P J, Masclee A AM, Spinhoven P, Schmidt J T, Zwinderman A H, Rabe K F, Bel E H. Risk factors of frequent exacerbations in difficult to treat asthma. Eur Resp J 2005; 26: 812–818
- Coughlan J L, Gibson P G, Henry R L. Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax 2001; 56: 198–204
- Gibson P G, Henry R L, Coughlan J L, Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database of Systematic Reviews 2003, Issue 1. Art CD001496. DOI: 10.1002/14651858.CD001496
- The BTS/SIGN British Guideline on the Management of Asthma April 2004 Update Thorax 2003. Vol 58, (supplement 1)
- Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2007, Available from http://www.ginasthma.org
- Harding S M, Guzzo M R, Richter J E. The prevalence of Gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000; 162: 34–39
- Kiljander T O, Salomaa E M, Hietanen E K, Terho E O. Gastroesophageal Reflux in Asthmatics. A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116: 1257–1264
- Everett C F, Kastelik J A, Mulrennan S A, Morice A H. Comment of Predictors of therapy resistant asthma. Thorax 2004; 59: 270–271
- Harding S M, Richter J L, Guzzo M R, Schan C A, Alexander R W, Bradley L A. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100: 395–405
- Kiljander T O, Harding S M, Field S K, Stein M R, Nelson H S, Ekelund J, Illueca M, Becknam O, Sostek M B. Effects of Esomeprazole 40 mg twice daily on asthma, a randomized placebo-controlled trial. Am J Resp Crit Care Med 2006; 173: 1091–1097
- Irwin R S, Curley F J, French C L. Difficult to control asthma: contributing factors and outcome of a systematic management protocol. Chest 1993; 103: 1662–1669
- British Society of Gastroenterology Guidelines for oesophageal manometry and pH monitoring. September, 1996, updated November 2006 http://www.bsg.org.uk
- Johnson L F, de Meester T R. Twenty-four hour pH monitoring of the distal oesophagus. Am J Gastroenterol 1974; 62: 325–332
- Stanton A E, Vaughn P, Bucknall C E. An observational investigation of hyperventilation and breathing control in a Problem Asthma Clinic. Thorax 2005; 60(suppl 2)ii42
- Alexander J A, Hunt L W, Patel A M. Prevalence, pathophysiology and treatment of patients with asthma and gastroesophageal reflux disease. Mayo Clin Proc 2000; 75: 1055–1063
- Gislason T, Janson C, Vermeire P, Plaschke P, Bjornsson E, Gillason D, Boman G. Respiratory symptoms and nocturnal gastroesophageal reflux. Chest 2002; 121: 158–163
- Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63: 14–20
- Farrokhi F, Vaezi M F. Extra-esophageal manifestations of gastroesophageal reflux. Oral Dis 2007; 13: 349–359
- Galmiche J P. Non erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs 2006; 66(suppl 1)7–13
- Kiljander T, Salomaa E R, Heeitanen E, Helenius H, Liippo K, Terho E O. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?. Resp Medicine 2001; 95: 387–392